Icatibant acetate

Drug ingredient

CAS 138614-30-9

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 138614-30-9
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

23 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
AmbioPharm, Inc.
Assia Chemical Industries Ltd - Teva Tech Site
Aurobindo Pharma Limited
Azico Biophore India Private Limited
Bachem AG
BCN PEPTIDES SA
Bryant Ranch Prepack
Chengdu Shengnuo Biopharm Co. Ltd.
Cipla USA Inc.
Cycle Pharmaceuticals Ltd-Uk
Dr.Reddy's laboratories Limited
Eugia US LLC
FRESENIUS KABI IPSUM SRL
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
MSN Life Sciences Private Limited
SUN PHARMACEUTICAL INDUSTRIES, INC.
Takeda Pharmaceuticals America, Inc.
Teva Pharmaceuticals USA, Inc.
USV Private Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • •Icatibant
  • •Firazyr
  • •Sajazir
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS138614-30-9
PubChem CID6918172
DTXSIDDTXSID201027613
FormulaC61H93N19O15S
Mol. Weight1364.6 g/mol
SMILESCC(=O)O.C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O

Data Sources

Brief citations

Icatibant acetate (CAS 138614-30-9) https://chemicalindependence.com/chemical/138614-30-9/ PubChem: 6918172. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/6918172 FDA National Drug Code directory: CAS 138614-30-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/